Clinical Trial Update: Clinical Significance of Hepatic and Circulating microRNAs miR-221 and miR-222 in Hepatocellular Carcinoma

View source ↗

Summary

This clinical trial update discusses the potential clinical significance of hepatic and circulating microRNAs miR-221 and miR-222 in hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: University of Aberdeen | Conditions: Hepatocellular Carcinoma | Status: UNKNOWN